NRG1: An Emerging Tumor Agnostic Target

Download All

Gain expert insight into the emerging role of NRG1 fusions as rare oncogenic drivers in a variety of solid tumors and learn about the targeted therapies in development from expert commentaries, a text-based module, and a downloadable slideset.

person default
Ryma Benayed, PhD
Stephen Liu, MD

Expert-Authored Online Activity

Learn how experts detect and treat NRG1 fusion–positive solid tumors in this interactive text module with expert perspectives from Stephen V. Liu, MD, and Ryma Benayed, PhD, on applying emerging research to biomarker testing and treatment strategies for patients with NRG1 fusion–driven cancers.

person default Ryma Benayed, PhD Stephen Liu, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: February 2, 2022 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In partnership with
Supported by an educational grant from
Elevation Oncology, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings